A Study on the Safety and Immune Response of a Booster Dose of Investigational COVID-19 mRNA Vaccines in Healthy Adults
Condition: SARS-CoV-2 Interventions: Biological: CV0701 Bivalent High dose; Biological: CV0701 Bivalent Medium dose; Biological: CV0701 Bivalent Low dose; Biological: CV0601 Monovalent High dose; Biological: Control vaccine Sponsors: GlaxoSmithKline; CureVac Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials